The Minimal Clinically Important Difference (MCID) for Total Joint Arthroplasty Outcome Measures Varies Substantially...

Area of Science:

• Orthopedics
• Health Services Research
• Biostatistics

Background:

• The transition to value-based healthcare emphasizes patient-reported outcomes.
• Minimal Clinically Important Difference (MCID) is crucial for assessing perceived surgical benefit.
• Ambiguity in MCID calculation methods affects the interpretation of surgical success.

Purpose of the Study:

• To evaluate the impact of different statistical methods on MCID values for total knee arthroplasty (TKA) and total hip arthroplasty (THA).
• To assess how variations in MCID calculation influence the number of patients achieving meaningful improvement after joint replacement.

Main Methods:

• Reviewed 1,113 patients undergoing TKA or THA with 1-year postoperative PROs (KOOS JR, HOOS JR).
• Determined MCID using 16 different statistical methods.
• Applied calculated MCID values to assess patient-reported outcomes and compare results across methods.

Main Results:

• MCID values varied substantially across the 16 methods evaluated (KOOS JR: 0.5-36.6; HOOS JR: 0.6-34.3).
• Distribution-based methods yielded smaller, more variable MCID values.
• Anchor-based methods produced larger, more consistent MCID values.

Conclusions:

• Different statistical approaches for MCID calculation lead to significant variations in threshold values.
• These variations impact the determination of patients meeting MCID, affecting the assessment of surgical benefit.
• The study highlights the ambiguity of MCID and raises questions about its reliability in evaluating total joint arthroplasty outcomes.